Denise P. Carter - Net Worth and Insider Trading
Denise P. Carter Net Worth
The estimated net worth of Denise P. Carter is at least $29,197 dollars as of 2024-11-13. Denise P. Carter is the COO of Quoin Pharmaceuticals Ltd and owns about 47,092 shares of Quoin Pharmaceuticals Ltd (QNRX) stock worth over $29,197. Details can be seen in Denise P. Carter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Denise P. Carter has not made any transactions after 2024-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Denise P. Carter
Denise P. Carter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Denise P. Carter owns 1 companies in total, including Quoin Pharmaceuticals Ltd (QNRX) .
Click here to see the complete history of Denise P. Carter’s form 4 insider trades.
Insider Ownership Summary of Denise P. Carter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNRX | Quoin Pharmaceuticals Ltd | 2024-09-04 | director & Chief Operating Officer |
Denise P. Carter Latest Holdings Summary
Denise P. Carter currently owns a total of 1 stock. Denise P. Carter owns 47,092 shares of Quoin Pharmaceuticals Ltd (QNRX) as of September 4, 2024, with a value of $29,197.
Latest Holdings of Denise P. Carter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals Ltd | 2024-09-04 | 47,092 | 0.62 | 29,197 |
Holding Weightings of Denise P. Carter
Denise P. Carter Form 4 Trading Tracker
According to the SEC Form 4 filings, Denise P. Carter has made a total of 1 transactions in Quoin Pharmaceuticals Ltd (QNRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Quoin Pharmaceuticals Ltd is the acquisition of 37,735 shares on September 4, 2024, which cost Denise P. Carter around $28,679.
Insider Trading History of Denise P. Carter
- 1
Denise P. Carter Trading Performance
GuruFocus tracks the stock performance after each of Denise P. Carter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Denise P. Carter is %. GuruFocus also compares Denise P. Carter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Denise P. Carter within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Denise P. Carter's insider trading performs compared to the benchmark.
Performance of Denise P. Carter
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -39.5 |  | | | | |
| Relative Return to S&P 500(%) | -43.68 | | | | | |
Denise P. Carter Ownership Network
Ownership Network List of Denise P. Carter
Ownership Network Relation of Denise P. Carter
Denise P. Carter Owned Company Details
What does Quoin Pharmaceuticals Ltd do?
Who are the key executives at Quoin Pharmaceuticals Ltd?
Denise P. Carter is the director & Chief Operating Officer of Quoin Pharmaceuticals Ltd. Other key executives at Quoin Pharmaceuticals Ltd include Chief Financial Officer Gordon Dunn , and director & Chief Executive Officer Michael Myers .
Quoin Pharmaceuticals Ltd (QNRX) Insider Trades Summary
Over the past 18 months, Denise P. Carter made 1 insider transaction in Quoin Pharmaceuticals Ltd (QNRX) with a net purchase of 37,735. Other recent insider transactions involving Quoin Pharmaceuticals Ltd (QNRX) include a net purchase of 37,894 shares made by Michael Myers , a net purchase of 28,856 shares made by Gordon Dunn , and a net sale of 297 shares made by Dennis Langer .
In summary, during the past 3 months, insiders sold 0 shares of Quoin Pharmaceuticals Ltd (QNRX) in total and bought 104,485 shares, with a net purchase of 104,485 shares. During the past 18 months, 297 shares of Quoin Pharmaceuticals Ltd (QNRX) were sold and 104,485 shares were bought by its insiders, resulting in a net purchase of 104,188 shares.
Quoin Pharmaceuticals Ltd (QNRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quoin Pharmaceuticals Ltd Insider Transactions
Denise P. Carter Mailing Address
Above is the net worth, insider trading, and ownership report for Denise P. Carter. You might contact Denise P. Carter via mailing address: Azrieli Center, Round Tower, 30th Floor, Tel Aviv L3 9701101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
